MS HB1467

Adds eight substances to Schedule I controlled substances, including brorphine, metonitazene, zipeprol, and eutylone, which have no legitimate medical use and high potential for harm

Adds daridorexant and zuranolone to Schedule IV controlled substances due to currently accepted medical use with low potential for abuse

Removes fenfluramine from Schedule IV controlled substances

Adds ganaxolone to Schedule V controlled substances

Effective date: July 1, 2024